Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Kees

Showing results (91-100 of 376) with videos related to

Pageof 38
Sort By:
Circulation. Genomic and Precision Medicine|February 1, 2022
Genetically Predicted Neutrophil-to-Lymphocyte Ratio and Coronary Artery Disease: Evidence From Mendelian RandomizationArjen J Cupido, Jordan M Kraaijenhof, Stephen Burgess, et al.
British Journal of Clinical Pharmacology|December 21, 2021
Dissecting the IL-6 pathway in cardiometabolic disease: A Mendelian randomization study on both IL6 and IL6RArjen J Cupido, Folkert W Asselbergs, Pradeep Natarajan, et al.
Journal of the American College of Cardiology|September 1, 2018
Effect of Long-Term Low Lipoproteins on Neurocognitive FunctionRutger Verbeek, S Matthijs Boekholdt, Robert Luben, et al.
Journal of the American Heart Association|April 26, 2019
Atorvastatin Has a Dose-Dependent Beneficial Effect on Kidney Function and Associated Cardiovascular Outcomes: Post Hoc Analysis of 6 Double-Blind Randomized Controlled TrialsLiffert Vogt, Sripal Bangalore, Rana Fayyad, et al.
BMC Medicine|April 26, 2023
Genetic evidence implicating natriuretic peptide receptor-3 in cardiovascular disease risk: a Mendelian randomization studyHéléne T Cronjé, Ville Karhunen, G Kees Hovingh, et al.
Therapeutic Drug Monitoring|October 21, 2020
Measurement of Free Plasma Concentrations of Beta-Lactam Antibiotics: An Applicability Study in Intensive Care Unit PatientsSelina Schießer, Florian Hitzenbichler, Martin G Kees, et al.
The American Journal of Cardiology|May 6, 2014
Statin and the risk of renal-related serious adverse events: Analysis from the IDEAL, TNT, CARDS, ASPEN, SPARCL, and other placebo-controlled trialsSripal Bangalore, Rana Fayyad, G Kees Hovingh, et al.
Current Atherosclerosis Reports|April 18, 2013
Genetics of HDL-C: a causal link to atherosclerosis?Julian C van Capelleveen, Andrea E Bochem, M Mahdi Motazacker, et al.
Atherosclerosis|January 9, 2016
Clinical phenotype in relation to the distance-to-index-patient in familial hypercholesterolemiaJoost Besseling, Roeland Huijgen, Seth S Martin, et al.
Atherosclerosis|November 26, 2020
Statin therapy reduces plasma angiopoietin-like 3 (ANGPTL3) concentrations in hypercholesterolemic patients via reduced liver X receptor (LXR) activationLaurens F Reeskamp, Tycho R Tromp, Roeland Huijgen, et al.
Pageof 38

Showing results (91-100 of 376) with videos related to

Sort By:
Pageof 38
Circulation. Genomic and Precision Medicine|February 1, 2022
Genetically Predicted Neutrophil-to-Lymphocyte Ratio and Coronary Artery Disease: Evidence From Mendelian RandomizationArjen J Cupido, Jordan M Kraaijenhof, Stephen Burgess, et al.
British Journal of Clinical Pharmacology|December 21, 2021
Dissecting the IL-6 pathway in cardiometabolic disease: A Mendelian randomization study on both IL6 and IL6RArjen J Cupido, Folkert W Asselbergs, Pradeep Natarajan, et al.
Journal of the American College of Cardiology|September 1, 2018
Effect of Long-Term Low Lipoproteins on Neurocognitive FunctionRutger Verbeek, S Matthijs Boekholdt, Robert Luben, et al.
Journal of the American Heart Association|April 26, 2019
Atorvastatin Has a Dose-Dependent Beneficial Effect on Kidney Function and Associated Cardiovascular Outcomes: Post Hoc Analysis of 6 Double-Blind Randomized Controlled TrialsLiffert Vogt, Sripal Bangalore, Rana Fayyad, et al.
BMC Medicine|April 26, 2023
Genetic evidence implicating natriuretic peptide receptor-3 in cardiovascular disease risk: a Mendelian randomization studyHéléne T Cronjé, Ville Karhunen, G Kees Hovingh, et al.
Therapeutic Drug Monitoring|October 21, 2020
Measurement of Free Plasma Concentrations of Beta-Lactam Antibiotics: An Applicability Study in Intensive Care Unit PatientsSelina Schießer, Florian Hitzenbichler, Martin G Kees, et al.
The American Journal of Cardiology|May 6, 2014
Statin and the risk of renal-related serious adverse events: Analysis from the IDEAL, TNT, CARDS, ASPEN, SPARCL, and other placebo-controlled trialsSripal Bangalore, Rana Fayyad, G Kees Hovingh, et al.
Current Atherosclerosis Reports|April 18, 2013
Genetics of HDL-C: a causal link to atherosclerosis?Julian C van Capelleveen, Andrea E Bochem, M Mahdi Motazacker, et al.
Atherosclerosis|January 9, 2016
Clinical phenotype in relation to the distance-to-index-patient in familial hypercholesterolemiaJoost Besseling, Roeland Huijgen, Seth S Martin, et al.
Atherosclerosis|November 26, 2020
Statin therapy reduces plasma angiopoietin-like 3 (ANGPTL3) concentrations in hypercholesterolemic patients via reduced liver X receptor (LXR) activationLaurens F Reeskamp, Tycho R Tromp, Roeland Huijgen, et al.
Pageof 38